Loading candles…
Mankind Pharma Limited, incorporated in 1995, operates primarily in the pharmaceutical and consumer healthcare industries within India. The company develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across acute and chronic therapeutic areas. It holds a significant position in the domestic Indian market, ranking fourth by value and second by volume in the Indian pharmaceutical sector. Mankind Pharma has transitioned from a marketing-led business model to a vertically integrated organization with notable manufacturing and research and development capabilities. Its product portfolio includes pharmaceutical formulations, consumer healthcare products, and pregnancy test kits, with more than 80% market share in key categories such as pregnancy test kits. The company does not list any key founders, key management personnel, subsidiaries, or stock exchange listings in the available information.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 19 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 3 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 6 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and dividend | 31 Jul 2025 |
| Audited Results - Q4 & FY25 | Pursuant to Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Boa… | 21 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.